Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement

QUA Nawab, E Golden, M Confalonieri… - Intensive care …, 2011 - Springer
Dear Editor, In a preliminary randomized trial of patients with severe communityacquired
pneumonia (CAP), we reported that glucocorticoid treatment was associated with …
被引用次数：26 相关文章
[PDF] academia.edu

[PDF][PDF] Qurrat-Ul-Ain Nawab Emmel Golden Marco Confalonieri Reba Umberger

GU Meduri - academia.edu
Dear Editor, In a preliminary randomized trial of patients with severe communityacquired
pneumonia (CAP), we reported that glucocorticoid treatment was associated with …

[引用][C] Corticosteroid treatment in severe community-acquired pneumonia: Duration of treatment affects control of systemic inflammation and clinical improvement

QUA Nawab, E Golden, M Confalonieri, R Umberger… - 2011 - ricerca.unityfvg.it
The duration of corticosteroid in severe community-acquired pneumonia affects control of
systemic inflammation and clinical improvement.

[引用][C] Corticosteroid treatment in severe community-acquired pneumonia: Duration of treatment affects control of systemic inflammation and clinical improvement

QUA Nawab, E Golden, M Confalonieri… - INTENSIVE CARE …, 2011 - arts.units.it
Corticosteroid treatment in severe community-acquired pneumonia: Duration of treatment affects
control of systemic inflammation and clinical improvement IRIS IRIS Home Sfoglia …

[引用][C] Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement

QUA NAWAB, E GOLDEN… - … care medicine (Print …, 2011 - pascal-francis.inist.fr
Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects
control of systemic inflammation and clinical improvement CNRS Inist Pascal-Francis CNRS …

Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement.

E Golden, M Confalonieri, R Umberger… - Intensive Care …, 2011 - go.gale.com
In a preliminary randomized trial of patients with severe community-acquired pneumonia
(CAP), we reported that glucocorticoid treatment was associated with attenuation of systemic …

[引用][C] Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement

E Golden, M Confalonieri, R Umberger… - Intensive Care …, 2011 - infona.pl
Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment
affects control of systemic inflammation and clinical improvement × Close The Infona portal …

Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement

E Golden, M Confalonieri, R Umberger… - Intensive Care …, 2011 - search.proquest.com
Dear Editor, In a preliminary randomized trial of patients with severe communityacquired
pneumonia (CAP), we reported that glucocorticoid treatment was associated with …

[引用][C] Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement

E Golden, M Confalonieri… - Intensive care …, 2011 - pubmed.ncbi.nlm.nih.gov
Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects
control of systemic inflammation and clinical improvement Corticosteroid treatment in severe …

[引用][C] Corticosteroid treatment in severe community-acquired pneumonia: Duration of treatment affects control of systemic inflammation and clinical improvement

QUA Nawab, E Golden, M Confalonieri, R Umberger… - 2011 - digitalcommons.memphis.edu
"Corticosteroid treatment in severe community-acquired pneumonia: Durat" by Qurrat Ul Ain
Nawab, Emmel Golden et al. Home Search Browse Collections My Account About DC Network …